Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-12-13
2005-12-13
Wilson, James O. (Department: 1623)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S022100, C536S024500, C536S025300, C536S025310, C536S025340, C536S025600, C536S026100, C435S087000, C435S090000, C435S091100, C435S091200, C435S091500
Reexamination Certificate
active
06974865
ABSTRACT:
The present invention is directed to nucleoside monomers wherein the 3′-O atom is replaced with a methylene group. The present invention also provides oligomers comprising a plurality of such monomers which are linked by methylene phosphonate linkages. Further, methods of preparing monomers and oligomers according to the present invention are provided.
REFERENCES:
patent: 3687808 (1972-08-01), Merigan et al.
patent: 4415732 (1983-11-01), Caruthers et al.
patent: 4458066 (1984-07-01), Caruthers et al.
patent: 4500707 (1985-02-01), Caruthers et al.
patent: 4668777 (1987-05-01), Caruthers et al.
patent: 4725677 (1988-02-01), Köster et al.
patent: 4973679 (1990-11-01), Caruthers et al.
patent: 5132418 (1992-07-01), Caruthers et al.
patent: RE34069 (1992-09-01), Köster et al.
patent: 5153319 (1992-10-01), Caruthers et al.
patent: 5212295 (1993-05-01), Cook
patent: 5334711 (1994-08-01), Sproat et al.
patent: 5453496 (1995-09-01), Caruthers et al.
patent: 5548076 (1996-08-01), Froehler et al.
patent: 5610289 (1997-03-01), Cook et al.
patent: 5614621 (1997-03-01), Ravikumar et al.
patent: 5670633 (1997-09-01), Cook et al.
patent: 5705621 (1998-01-01), Ravikumar
patent: 5705629 (1998-01-01), Bhongle
patent: 5760209 (1998-06-01), Cheruvallath et al.
patent: 5783690 (1998-07-01), Cheruvallath et al.
patent: 6166197 (2000-12-01), Cook et al.
patent: 6172209 (2001-01-01), Manoharan et al.
patent: 6271358 (2001-08-01), Manoharan et al.
patent: WO 96/08503 (1996-03-01), None
patent: WO 97/32887 (1997-09-01), None
Agrawal et al. (eds.), “Methods of Molecular Biology”, inProtocols for Oligonucleotide Conjugates, Agrawal, S. (ed.), Humana Press, New Jersey, 1994, vol. 26, 1-72.
Albrecht, H.P. et al., “Synthesis of Isosteric Phosphonate Analogs of Some Biologically Important Phosphodiesters”,J. Am. Chem. Soc., 1970, 92, 5510-5513.
Albrecht et al., “Homonucleoside Phosphonic Acids—I—A General Synthesis of Isosteric Phosphonate Analogs of Nucleoside 3′-Phosphates,”Tetrahedron, 1984, 40(1), 79-85.
Alul, R.H. et al., “Oxalyl-CPG: a labile support for synthesis of sensitive oligonucleotide derivatives”,Nucl. Acid Res., 1991, 19, 1527-1532.
Beaucage, S.L. et al., “The Functionalization of Oligonucleotides Via Phosphoramidite Derivatives,”Tetrahedron, 1993, 49(10), 1925-1963.
Beaucage, S.L. et al., “The Synthesis of Specific Ribonucleotides and Unrelated Phosphorylated Biomolecules by the Phosphoramidite Method,”Tetrahedron, 1993, 49(46), 10441-10488.
Beaucage, S.L. et al., “Advances in the Synthesis of Oligonucleotides by the Phosphoramidite Approach”,Tetrahedron, 1992, 48, 2223-2311.
Bhat, B. et al., “Synthesis of Novel Nucleic Acid Mimics via the Stereoselective Intermolecular Radical Coupling of 3′-Iodo Nucleosides and Formaldoximines”,J. Org. Chem., 1996, 61, 8186-8199.
Breaker et al., “Synthesis and Properties of Adenosine Oligonucleotide Analogues Containing Methylene Groups in Place of Phosphodiester 5′-Oxygens,”Biochem., 1993, 32, 9125-9128.
Brown, T. et al., “Modern machine-aided methods of oligodeoxyribonucleotide synthesis,”Oligonucleotides and Analogues: A Practical Approach, 1991, Chapter 1, Eckstein, F. (ed.), IRL Press, New York, 1-24.
Cook, P.D., “Medicinal Chemistry of Antisense Oligonucleotides—future opportunities”,Anti-Cancer Drug Design, 1991, 6, 585-607.
Cormier, J.F. et al., “Synthesis of hexanucleotide analogues containing diisopropylsilyl internucleotide linkages”,Nucl. Acids Res., 1988, 16, 4583-4594.
Crooke, S.T. et al., “Pharmacokinetic Properties of Several Novel Oligonucleotide Analogs in mice”,J. Pharmacol. Exp. Therapeutics, 1996, 277, 923-937.
Delgado, C. et al., “The Uses and Properties of PEG-Linked Proteins”,Crit. Rev. in Therapeutic Drug Carrier Sys., 1992, 9, 249-304.
Derry et al., “Synthesis and biological activity of novel thymidine derivatives of podophyllotoxin and 4′-demethylepipodophyllotoxin,”Anti-Cancer Drug Design, 1993, 8, 203-221.
Englisch, U. et al., “Chemically Modified Oligonucleotides as Probes and Inhibitors”,Angew. Chem. Int. Ed. Eng., 1991, 30, 613-629.
Froehler et al., “Nucleoside H-Phosphonates: Valuable Intermediates in the Synthesis of Deoxyoligonucleotides,”Tetra. Lett., 1986, 27(4), 469-472.
Goodchild, J., “Conjugates of Oligonucleotides and Modified Oligonucleotides: A Review of their synthesis and Properties”,Bioconjugate Chem., 1990, 1, 165-187.
Hamm, M. L. et al., “Incorporation of 2′-Deoxy-2′-mercaptocytidine into Oligonucleotides via Phosphoramidite Chemistry,”J. Org. Chem., 1997, 62, 3415-3420.
Heinemann, U. et al., “Effect of a single 3′-methylene phosphonate linkage on the conformation of an A-DNA octamer double helix”,Nucl. Acids Res., 1991, 19, 427-433.
Kabanov, A.V., “A new class of antivirals: antisense olgonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus-specific proteins in MDCK cells”,FEBS Letts., 1990, 259, 327-330.
Kroschwitz, J.I., “Polynucleotides”,Concise Encyclopedia of Polymer Science and Engineering, 1990, John Wiley & Sons, New York, 858-859.
Lebreton, J. et al., “Comparison of two Amides as Backbone Replacement of the Phosphodiester Linkage in Oligodeoxynucleotides,”Tetrahedron Letts., 1994, 35, 5225-5228.
Letsinger, R.L. et al.. “Cholesteryl-conjugated oligonucleotides: Synthesis, properties and activity as inhibitors of replication of human immunodeficiency virus in cell culture”,Proc. Natl. Acad. Sci., 1989, 86, 6553-6556.
Loke, S.L. et al., “Delivery ofc-mycAntisense Phoshorothioate Oligodeoxynucleotides to Hemopoietic Cells in Culture by Liposome Fusion: Specific Reduction inc-mycProtein Expression Correlates with Inhibition of Cell Growth and DNA Synthesis”,Curr. Topics in Microbiol. &Immunol., 1988, 141, 282-289.
Manoharan, M. et al., “Introduction of a Lipophilic Thioether Tether in the Minor Groove of Nucleic Acids for Antisense Applications”,Bioorg. Med. Chem. Letts., 1993, 3, 2765-2770.
Manoharan M. et al., “Oligonucleotide Conjugates: Alteration of the Pharmacokinetic Properties of Antisense Agents”,Nucleosides and Nucleotides, 1995, 14, 969-973.
Manoharan M. et al, “Cholic Acid-Oligonucliotide Conjugates for Antisense Applications”,Bioorganic Med. Chem. Letts., 1994, 4, 1053-1060.
Manoharan, M. et al., “Chemical Modifications to Improve Uptake and Bioavailability of Antisense Oligonucleotides”,Annals NY Acad. Sciences, 1992, 660, 306-309.
Manoharan, M. et al., “Lipidic Nucleic Acids”,Tetrahedron Letts., 1995, 36, 3651-3654.
Marcus-Sekura, C.J. et al., “Comparative inhibition of chloramphenicol acetyltransferase gene expression by antisense oligonucleotide analogues having alkyl phosphotriester, methylphosphonate and phosphorothioate linkages”,Nucl. Acids Res., 1987, 15, 5749-5763.
Matteucci, M., “Deoxyoligonucleotide Analogs Based on Formacetal Linkages”,Tetrahedron Letts., 1990, 31, 2385-2388.
Mazur, A. et al., “Isoteres of Natural Phosphates. 11. Synthesis of a Phosphonic Acid Analogur of an Oligonucleotide”,Tetrahedron, 1984, 40, 3949-3956.
McConnell et al., “Phosphorus-Containing Derivatives of 2,2-Dimethyl-1, 3-propanediol,”J. Org. Chem., 1959, 24, 630-635.
Mihkailov et al., “Ribosylation of Pyrimidine 2′-Deoxynucleosides,”Nucleosides and Nucleotides, 1996, 15(7&8), 1323-1334.
Miller, P.S. et al., “Effects of a Trinucleotide Ethyl Phosphotriester, Gmp(Et)Gmp(Et)U, on Mammalian Cells in Culture”,Biochem., 1977, 16, 1988-1996.
Mishra, R.K. et al., “Improved leishmanicidal effect of phosphorotioate antisense oligonucl
An Haoyun
Cook Phillip Dan
Maier Martin
Manoharan Muthiah
Isis Patent Department
ISIS Pharmaceuticals Inc.
McIntosh III Traviss C.
Wilson James O.
LandOfFree
C3′ -methylene hydrogen phosphonate oligomers and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with C3′ -methylene hydrogen phosphonate oligomers and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and C3′ -methylene hydrogen phosphonate oligomers and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3502391